Home

The war on glaucoma blindness takes place on three fronts: clinical care, teaching, and research.

The University of Iowa is at the forefront in all three of these arenas:

  • Providing the highest quality patient care with the latest technology – Learn More
  • Educating clinicians, researchers, students and patients – Learn More
  • Researching the causes of glaucoma and developing tools to aid in diagnosis and treatment – Learn More

Recent News

  • Fri, 12/02/2016 - 08:15

    University of Iowa resident physician, Dr. Mathew Miller and faculty members Dan Bettis and John Fingert authored an article reviewing the utility of genetic testing for glaucoma in 2016. Read more about it here.

  • Mon, 11/21/2016 - 06:45

    A research team led by Drs. Kuehn and Kwon designed a new formulation of the standard timolol glaucoma medicine that successfully lowered eye pressure for up to 90 days in animal studies. The team engineered a long-lasting form of timolol that is injected underneath the outer covering of the eye (the conjunctiva) where it has pressure-lowering effects for months. Read more about the development of this new formulation of timolol here.

  • Wed, 10/26/2016 - 18:45

    Glaucoma Center faculty Dr. Wallace LM Alward and John H Fingert discuss genetic testing and glaucoma in an article by the American Academy of Ophthalmology’s EyeNet. Read the article here.